Biosafety Guidelines for Novel Coronavirus (SARS-CoV-2) – Coronavirus disease (COVID-19)

The following biosafety guidelines are available to assist laboratories in the safe handling of samples containing the novel coronavirus (2019-nCoV).

World Health Organization

Assessment tool for laboratories implementing COVID-19 virus testing  Access the tool

Diagnostic testing for SARS-CoV-2, 11 September 2020

Emerging respiratory viruses, including nCoV: methods for detection, prevention, response and control

Guide to Local Production – WHO recommended Hand-rub formulations, PDF FileWHO Link

Infection Prevention and Control (IPC) for Novel Coronavirus (COVID-19)

Infection prevention and control during health care when novel coronavirus (nCoV) infection is suspected, Interim guidance 19 March 2020

Infection prevention and control for the safe management of a dead body in the context of COVID-19: interim guidance 4 September 2020

Laboratory assessment tool for laboratories implementing SARS-CoV-2 testing, 23 October 2020

Laboratory biosafety guidance related to coronavirus disease (COVID-19): Interim guidance, 28 January 2021

Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases, Interim guidance 19 March 2020

Mask use in the context of COVID-19, update 1 December 2020

Naming the coronavirus disease (COVID-2019) and the virus that causes it (SARS-CoV-2)

Operational considerations for managing COVID-19 cases or outbreak in aviation, Interim guidance 18 March 2020

Personal protective equipment (PPE) – How to put on and take off

Prevention, identification and management of health worker infection in the context of COVID-19, 30 October 2020

Rational use of personal protective equipment for coronavirus disease (COVID-19) and considerations during severe shortages, update 23 December 2020

Severe Acute Respiratory Infections Treatment Centre, Interim guidance 28 March 2020

Technical specifications of personal protective equipment for COVID-19, 13 November 2020

Transmission of SARS-CoV-2: implications for infection prevention precautionsScientific Brief, 9 July 2020

Africa

Africa CDC COVID-19 Resources

ECDC

Heating, ventilation and air-conditioning systems in the context of COVID-19, 22 June 2020

Infection prevention and control for COVID-19 in healthcare settings, March 2020

Interpol

COVID-19 Pandemic Guidelines for Law enforcement

Public Health Agency of Canada

Novel Coronavirus from Wuhan, China (2019-nCoV) Biosafety Advisory

Sandia

The Global Chemical and Biological Security Group (GCBS) at Sandia National Laboratories (SNL) has developed a library of mini-courses designed to support biological threat reduction efforts in fighting the COVID-19 pandemic. Mini-courses targeted for personnel working in or supporting clinical, diagnostic, or research laboratories in which samples or specimens potentially containing SARS-CoV-2 may be received, manipulated, stored, or disposed.

Singapore

Interim Biosafety Guidelines for Laboratories and Personnel Handling Samples or Materials Associated with the 2019 Novel Coronavirus (2019-nCoV)

United Kingdom

Handling and processing of laboratory specimens, Guidance – Wuhan novel coronavirus

Packaging requirements for COVID-19 samples

Suspected COVID-19 cases – samples and packaging

US Centers for Disease Control and Prevention

Best Practices for Environmental Cleaning in Healthcare Facilities in Resource Limited Settings

Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Patients Under Investigation (PUIs) for 2019 Novel Coronavirus (2019-nCoV)

Interim Laboratory Biosafety Guidelines for Handling and Processing Specimens Associated with 2019 Novel Coronavirus (2019-nCoV)

Other Guidance and Resources

Biorisk management in laboratories handling SARS-CoV-2 (COVID-19) samples – AEBioS Poster

COVID-19: Proper Glove Removal – The “Beaking” Method

Overview of 12 facts about the COVID-19 virus in water, TU Delft | Global Drinking Water